U.S. Medical Grade Sodium Bicarbonate Market Deep Industry Analysis

U.S. Medical Grade Sodium Bicarbonate Market

for Hospitals - Size, Trend, Share, Opportunity Analysis, and Forecast, 2014-2016

  • Date Healthcare
  • Date January 2018
  • price $3995
 
 

U.S. Medical Grade Sodium Bicarbonate Market - Overall Industry Analysis

Progressive Markets published a report,U.S. Medical Grade Sodium Bicarbonate Market - Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2025”, which says that U.S. medical grade sodium bicarbonate market is expected to grow at a CAGR of over 4.4% from 2014 to 2016.

Sodium bicarbonate belongs to a member of medicine group known as antacids. Taken intravenously, it is used to raise the concentration of plasma bicarbonate and increase buffer excess hydrogen ions and blood pH. The administration of the medicine helps to restore the plasma pH within the normal range. Therefore, it is widely used to normalize pH by neutralizing excessive stomach acids in patients suffering from acidosis. Widely used in the medical industry, the chemical finds application in the treatment of several conditions such as metabolic acidosis, cardiac arrest, and renal indications.

Market Drivers and Restraints:

The report throws light on the factors that govern the growth of the U.S. medical grade sodium bicarbonate market. They include the high occurrence of disorders related to acidosis, the rise in demand for sodium bicarbonate during heart surgery and the rise in number of patients undergoing chemotherapy. Moreover, an increase in demand for use of the drug in heart surgery and chemotherapy treatment provides a major opportunity for market expansion. On the other hand, the likelihood of negative effects such as headache, nausea, and irritability due to high dose of the medicine is likely to impede the growth of the industry.

Market Segmentation:

The report studies the U.S. medical grade sodium bicarbonate market segmented by state. Based on state, the industry analysis is covered for Arizona, Nevada, New Mexico, Utah, Colorado, Oregon, Washington, and Hawaii.

Key Market Players:

The study also identifies the market players operating in the U.S. medical grade bicarbonate market. They adopt various strategies such as product launches, partnerships, mergers & acquisitions, and more to survive and grow in the marketplace. The key market players in the market include Amphastar Pharmaceuticals, Inc., Hospira, Inc. (Pfizer), Cardinal Health, Athenex, Inc., Nephron Pharmaceuticals Corporation, QuVa Pharma, Inc., Rugby Laboratories, Richmond Pharmaceuticals, Inc., and Menper Distributors Inc.

MARKET LANDSCAPE

By State

  • Arizona

  • Nevada

  • New Mexico

  • Utah

  • Colorado

  • Oregon

  • Washington

  • Hawaii

Key Benefits from the Report:

The U.S. medical grade sodium bicarbonate market report covers an extensive analysis of the industry on a global level. It encompasses the U.S. medical grade sodium bicarbonate market size, U.S. medical grade sodium bicarbonate market share analysis, market dynamics, industry statistics, market trends, Porter’s Five Forces Analysis (PFFA), market segmentation, company profiles, market scope and definitions, market forecast, and company profiles. The market size explains where the market stands and where it is going. The study provides an analysis of the historic market size from 2014 to 2017 along with a market forecast from 2018 to 2025 for every segment and region. The market share analysis helps tell about the performance of the players in the market as compared to their competitors. The U.S. medical grade sodium bicarbonate industry statistics, charts, and graphs support the information provided in the report. The drivers and restraints of the industry along with their effects on the market help identify the potential areas of growth. The U.S. medical grade sodium bicarbonate market forecast helps assess the future potential of the market. To help understand the competitive landscape of the U.S. medicate grade sodium bicarbonate industry, the report offers an analysis of the Porter’s Five Forces model. The model constitutes the bargaining power of buyers, bargaining power of suppliers, the threat of substitutes, the threat of new entrants, and industry rivalry. The prime players participating in the industry and information on their recent developments, marketing strategies, and more help determine the growth opportunities in the U.S. medicate grade sodium bicarbonate industry.

CHAPTER ONE. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools
CHAPTER TWO. EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER THREE. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. MARKET SCENARIO
3.2.1. Derivation from soda ash
3.2.2. Product description and medical application
3.2.3. Current scenario of the market
3.2.3.1. Product recalled by Hospira, Inc.
3.2.3.2. Shortage of drugs available in the market
3.2.4. Addressing the shortage of sodium bicarbonate
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Increase in geriatric population
3.3.1.2. Rise in awareness towards the benefits offered by the drug
3.3.2. Restraints
3.3.2.1. Adverse effects of the drug
3.3.3. Opportunity
3.3.3.1. Surge in demand for the drug
CHAPTER FOUR. U.S. MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE
4.1. OVERVIEW
4.1.1. Key market trends
4.1.2. Market size and forecast
CHAPTER FIVE. ARIZONA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. MARKET SHARE, 2016
5.3.1. Hospira, Inc. (Pfizer, Inc.)
5.3.2. Amphastar Pharmaceuticals, Inc.
5.3.3. Athenex, Inc.
5.3.4. Others
CHAPTER SIX. NEVADA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
6.1. OVERVIEW
6.2. MARKET SIZE AND FORECAST
6.3. MARKET SHARE, 2016
6.3.1. Hospira, Inc. (Pfizer, Inc.)
6.3.2. Amphastar Pharmaceuticals, Inc.
6.3.3. Athenex, Inc.
6.3.4. Others
CHAPTER SEVEN. NEW MEXICO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
7.1. OVERVIEW
7.2. MARKET SIZE AND FORECAST
7.3. MARKET SHARE, 2016
7.3.1. Hospira, Inc. (Pfizer, Inc.)
7.3.2. Amphastar Pharmaceuticals, Inc.
7.3.3. Athenex, Inc.
7.3.4. Others
CHAPTER EIGHT. UTAH MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
8.1. OVERVIEW
8.2. MARKET SIZE AND FORECAST
8.3. MARKET SHARE, 2016
8.3.1. Hospira, Inc. (Pfizer, Inc.)
8.3.2. Amphastar Pharmaceuticals, Inc.
8.3.3. Athenex, Inc.
8.3.4. Others
CHAPTER NINE. COLORADO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
9.1. OVERVIEW
9.2. MARKET SIZE AND FORECAST
9.3. MARKET SHARE, 2016
9.3.1. Hospira, Inc. (Pfizer, Inc.)
9.3.2. Amphastar Pharmaceuticals, Inc.
9.3.3. Athenex, Inc.
9.3.4. Others
CHAPTER TEN. OREGON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
10.1. OVERVIEW
10.2. MARKET SIZE AND FORECAST
10.3. MARKET SHARE, 2016
10.3.1. Hospira, Inc. (Pfizer, Inc.)
10.3.2. Amphastar Pharmaceuticals, Inc.
10.3.3. Athenex, Inc.
10.3.4. Others
CHAPTER ELEVEN. WASHINGTON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
11.1. OVERVIEW
11.2. MARKET SIZE AND FORECAST
11.3. MARKET SHARE, 2016
11.3.1. Hospira, Inc. (Pfizer, Inc.)
11.3.2. Amphastar Pharmaceuticals, Inc.
11.3.3. Athenex, Inc.
11.3.4. Others
CHAPTER TWELVE. HAWAII MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
12.1. OVERVIEW
12.2. MARKET SIZE AND FORECAST
12.3. MARKET SHARE ANALYSIS, 2016
12.3.1. Hospira, Inc. (Pfizer, Inc.)
12.3.2. Amphastar Pharmaceuticals, Inc.
12.3.3. Athenex, Inc.
12.3.4. Others

List of Tables

TABLE CURRENT AND RESOLVED DRUG SHORTAGE AND DISCONTINUATIONS REPORTED TO FDA
TABLE U.S. MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE ARIZONA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE NEVADA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE NEW MEXICO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE UTAH MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE COLORADO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE OREGON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE WASHINGTON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE HAWAII MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)

List of Figures

FIGURE SODA ASH COMPONENTS AND USE
FIGURE SODA ASH CONSUMPTION BY SEGMENTS
FIGURE ARIZONA MARKET SHARE ANALYSIS, 2016
FIGURE NEVADA MARKET SHARE ANALYSIS, 2016
FIGURE NEW MEXICO MARKET SHARE ANALYSIS, 2016
FIGURE UTAH MARKET SHARE ANALYSIS, 2016
FIGURE COLORADO MARKET SHARE ANALYSIS, 2016
FIGURE OREGON MARKET SHARE ANALYSIS, 2016
FIGURE WASHINGTON MARKET SHARE ANALYSIS, 2016
FIGURE HAWAII MARKET SHARE ANALYSIS, 2016
License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Similar Market Research Report

blog
Apr
2018
Chatbot for banking Market

The global Chatbot for banking market was valued at $278 million in 2016, and is projected to reach $2,154 million by 2024, growing at a CAGR of 29.6% from 2018 to 2024. Read More >>

 

Get Email Alert